What does it do? Beta-glucan is a fiber-type polysaccharide
(complex sugar) derived from the cell wall of baker’s yeast,
oat and barley fiber, and many medicinal mushrooms,
such as maitake. In their natural state, yeast and mushrooms
contain a mixture of beta-1,3-glucan and beta-1,6-glucan. Oats and barley contain a mixture of
beta-1,3-glucan and beta-1,4-glucan. In addition to purified beta-1,3-glucan from these
sources, you may see products listed as beta-1,3/1,6-glucan in the case of yeast-derived
products and as beta-1,3/1,4-glucan when derived from oats. Similar (if not identical)
properties have been shown for beta-glucan–rich extracts and purified beta-glucan
derived from oats, baker’s yeast, and
mushrooms. The two primary uses of beta-glucan are to enhance the immune system and to lower blood cholesterol levels.
Numerous experimental studies in test tubes and animals have shown beta-glucan to activate
white blood cells.1 2 3 4 5 In fact,
there have been hundreds of research papers on beta-glucan since the 1960s.6 The
research indicates that beta-1,3-glucan, in particular, is very effective at activating white
blood cells known as macrophages and neutrophils. These cells provide one of the immune
system’s first lines of defense against foreign invaders. A beta-glucan–activated
macrophage or neutrophil can recognize and kill tumor cells, remove cellular debris resulting
from oxidative damage, speed up recovery of damaged tissue, and further activate other
components of the immune system.7 8 Although the research in test tube
and animal studies is promising, many questions remain about the effectiveness of beta-glucan
as an oral supplement to enhance immune function in humans.
Beta-glucan is the key factor for the cholesterol-lowering effect of oat bran.9
10 11 12 13 As with other soluble-fiber
components, the binding of cholesterol (and bile acids) by beta-glucan and the resulting
elimination of these moleculesin, the feces is very helpful for reducing blood
cholesterol.14 15 16 Results from a number of double-blind
trials with either oat- or yeast-derived beta-glucan indicate typical reductions, after at
least four weeks of use, of approximately 10% for total cholesterol and 8% for LDL
(“bad”) cholesterol, with elevations in HDL (“good”) cholesterol
ranging from zero to 16%.17 18 19 20
21
Like other sources of soluble fiber, beta-glucan is,
according to preliminary studies, helpful in reducing the elevation in blood sugar levels that
typically follow a meal.22 23 24 25 Beta-glucan
produces this effect by delaying gastric emptying so that dietary sugar is absorbed more
gradually, as well as by possibly increasing the tissue sensitivity to insulin. These effects suggest possible benefit in blood sugar
control in people with diabetes.
References:
1. Czop JK. The role of beta-glucan receptors on blood and tissue
leukocytes in phagocytosis and metabolic activation. Pathol Immunopathol Res
1986;5:286–96.
2. Wakshull E, Brunke-Reese D, Lindermuth J, et al. PGG-glucan, a soluble
beta-(1,3)-glucan, enhances the oxidative burst response, microbicidal activity, and activates
an NF-kappa B-like factor in human PMN: evidence for a glycosphingolipid beta-(1,3)-glucan
receptor. Immunopharmacology 1999;41:89–107.
3. Czop JK, Kay J. Isolation and characterization of beta-glucan
receptors on human mononuclear phagocytes. J Exp Med 1991;173:1511–20.
4. Czop JK, Puglisi AV, Miorandi DZ, Austen KF. Perturbation of
beta-glucan receptors on human neutrophils initiates phagocytosis and leukotriene B4
production. J Immunol 1988;141:3170–6.
5. Estrada A, Yun CH, Van Kessel A, et al. Immunomodulatory activities of
oat beta-glucan in vitro and in vivo. Microbiol Immunol 1997;41:991–8.
6. Ooi VE, Liu F. Immunomodulation and anti-cancer activity of
polysaccharide-protein complexes. Curr Med Chem 2000;7:715–29 [review].
7. Ross GD, Vetvicka V, Yan J, et al. Therapeutic intervention with
complement and beta-glucan in cancer. Immunopharmacology 1999;42:61–74.
8. Di Renzo L, Yefenof E, Klein E. The function of human NK cells is
enhanced by beta-glucan, a ligand of CR3 (CD11b/CD18). Eur J Immunol 1991
Jul;21:1755–8.
9. Bell S, Goldman VM, Bistrian BR, et al. Effect of beta-glucan from
oats and yeast on serum lipids. Crit Rev Food Sci Nutr 1999;39:189–202
[review].
10. Bell S, Goldman VM, Bistrian BR, et al. Effect of beta-glucan from
oats and yeast on serum lipids. Crit Rev Food Sci Nutr 1999;39:189–202
[review].
11. Behall KM, Scholfield DJ, Hallfrisch J. Effect of beta-glucan level
in oat fiber extracts on blood lipids in men and women. J Am Coll Nutr
1997;16:46–51.
12. Braaten JT, Wood PJ, Scott FW, et al. Oat beta-glucan reduces blood
cholesterol concentration in hypercholesterolemic subjects. Eur J Clin Nutr
1994;48:465–74.
13. Davidson MH, Dugan LD, Burns JH, et al. The hypocholesterolemic
effects of beta-glucan in oatmeal and oat bran. A dose-controlled study. JAMA
1991;265:1833–9.
14. Wood PJ. Physicochemical properties and physiological effects of the
(1----3)(1----4)-beta-D-glucan from oats. Adv Exp Med Biol 1990;270:119–27.
15. Uusitupa MI, Miettinen TA, Sarkkinen ES, et al. Lathosterol and other
non-cholesterol sterols during treatment of hypercholesterolaemia with beta-glucan-rich oat
bran. Eur J Clin Nutr 1997;51:607–11.
16. Lia A, Hallmans G, Sandberg AS, et al. Oat beta-glucan increases bile
acid excretion and a fiber-rich barley fraction increases cholesterol excretion in ileostomy
subjects. Am J Clin Nutr 1995;62:1245–51.
17. Bell S, Goldman VM, Bistrian BR, et al. Effect of beta-glucan from
oats and yeast on serum lipids. Crit Rev Food Sci Nutr 1999;39:189–202
[review].
18. Nicolosi R, Bell SJ, Bistrian BR, et al. Plasma lipid changes after
supplementation with beta-glucan fiber from yeast. Am J Clin Nutr
1999;70:208–12.
19. Behall KM, Scholfield DJ, Hallfrisch J. Effect of beta-glucan level
in oat fiber extracts on blood lipids in men and women. J Am Coll Nutr
1997;16:46–51.
20. Braaten JT, Wood PJ, Scott FW, et al. Oat beta-glucan reduces blood
cholesterol concentration in hypercholesterolemic subjects. Eur J Clin Nutr
1994;48:465–74.
21. Uusitupa MI, Ruuskanen E, Makinen E, et al. A controlled study on the
effect of beta-glucan-rich oat bran on serum lipids in hypercholesterolemic subjects: relation
to apolipoprotein E phenotype. J Am Coll Nutr 1992;11:651–9.
22. Braaten JT, Scott FW, Wood PJ, et al. High beta-glucan oat bran and
oat gum reduce postprandial blood glucose and insulin in subjects with and without type 2
diabetes. Diabet Med 1994;11:312–8.
23. Wood PJ. Physicochemical properties and physiological effects of the
(1----3)(1----4)-beta-D-glucan from oats. Adv Exp Med Biol 1990;270:119–27.
24. Bourdon I, Yokoyama W, Davis P, et al. Postprandial lipid, glucose,
insulin, and cholecystokinin responses in men fed barley pasta enriched with beta-glucan.
Am J Clin Nutr 1999;69:55–63.
25. Pick ME, Hawrysh ZJ, Gee MI. Oat bran concentrate bread products
improve long-term control of diabetes: a pilot study. J Am Diet Assoc
1996;96:1254–61.